{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:55:34Z","timestamp":1774702534504,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.htct.2025.106225","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:02:47Z","timestamp":1765008167000},"page":"106225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3401-4086","authenticated-orcid":false,"given":"Roy","family":"Khalife","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Perelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-0242","authenticated-orcid":false,"given":"Darine","family":"El-Cha\u00e2r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Karovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Tokessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-3344","authenticated-orcid":false,"given":"Kathryn E.","family":"Webert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Tinmouth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0001","first-page":"28","article-title":"Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program","volume":"6","author":"Feasby","year":"2012","journal-title":"Open Med"},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.htct.2025.106225_bib0003","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg [5]","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.htct.2025.106225_bib0004","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2133.2002.04833.x","article-title":"A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis","volume":"147","author":"Paul","year":"2002","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.htct.2025.106225_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00043426-200210000-00008","article-title":"Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children","volume":"24","author":"Ancona","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2257.1995.tb00322.x","article-title":"Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia","volume":"17","author":"Boughton","year":"1995","journal-title":"Clin Lab Haematol"},{"issue":"4","key":"10.1016\/j.htct.2025.106225_bib0007","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"issue":"8905","key":"10.1016\/j.htct.2025.106225_bib0008","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(94)90180-5","article-title":"Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma","volume":"343","author":"Chapel","year":"1994","journal-title":"Lancet"},{"issue":"9047","key":"10.1016\/j.htct.2025.106225_bib0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome","volume":"349","author":"Hughes","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.htct.2025.106225_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aji.13615","article-title":"Efficacy of intravenous immunoglobulin in the treatment of recurrent spontaneous abortion: A systematic review and meta-analysis","volume":"88","author":"Shi","year":"2022","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.htct.2025.106225_bib0011","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1067\/mai.2001.117821","article-title":"Obstetric uses of intravenous immunoglobulin: successes, failures, and promises","volume":"108","author":"Branch","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.htct.2025.106225_bib0012","unstructured":"Biotext Science Information Consultants (Canberra ACT., (Australia) NBA. A systematic literature review and report on the efficacy of intravenous immunoglobulin therapy and its risks [electronic resource]: final report v04 \/Biotext Science Information Consultants. 2004."},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0013","first-page":"11","article-title":"Intravenous immune globulin use in Canada","volume":"10","author":"Hanna","year":"2003","journal-title":"Can J Clin Pharmacol = J Can Pharmacol Clin"},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0014","first-page":"E0314","article-title":"Single-center experience of outcomes and prescribing patterns of IV immunoglobulin use in critically ill patients","volume":"3","author":"Torbic","year":"2021","journal-title":"Crit Care Explor"},{"issue":"11","key":"10.1016\/j.htct.2025.106225_bib0015","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/j.1537-2995.2007.01400.x","article-title":"Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: A report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group","volume":"47","author":"Constantine","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.htct.2025.106225_bib0016","series-title":"Clinical Guide To Transfusion [Internet] [Internet]","article-title":"Immunoglobulin products","author":"Harding","year":"2024"},{"key":"10.1016\/j.htct.2025.106225_bib0017","unstructured":"Ontario Regional Blood Coordinating Network (ORBCON), Ontario Immune Globulin (IG) Utilization Management Guidelines. 2018;0\u201311."},{"issue":"5","key":"10.1016\/j.htct.2025.106225_bib0018","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1537-2995.2006.00792.x","article-title":"Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature","volume":"46","author":"Darabi","year":"2006","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2012-08-448944","article-title":"Stasi R. How I treat thrombocytopenia in pregnancy","volume":"121","author":"Gernsheimer","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.htct.2025.106225_bib0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2025.106225_bib0021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tracli.2020.12.005","article-title":"Review of indications for immunoglobulin (IG) use: narrowing the gap between supply and demand","volume":"28","author":"Brand","year":"2021","journal-title":"Transfus Clin Biol [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2025.106225_bib0022","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"January","key":"10.1016\/j.htct.2025.106225_bib0023","first-page":"1","article-title":"Development, implementation and impact of an immunoglobulin stewardship programme in Saskatchewan","author":"Sarker","year":"2024","journal-title":"Canada. Vox Sang."},{"issue":"3","key":"10.1016\/j.htct.2025.106225_bib0024","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1200\/OP.20.00312","article-title":"Changes in intravenous immunoglobulin usage for hypogammaglobulinemia after implementation of a stewardship program","volume":"17","author":"Derman","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"19","key":"10.1016\/j.htct.2025.106225_bib0025","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2146\/ajhp070582","article-title":"Unlabeled uses of intravenous immune globulin","volume":"65","author":"Leong","year":"2008","journal-title":"Am J Heal Pharm"},{"key":"10.1016\/j.htct.2025.106225_bib0026","unstructured":"Canadian Blood Services, National Advisory Committee on Blood and Blood Products. The National Plan for Management of Shortages of Immunoglobulin Products (Ig) \u2013 Interim Guidance. 2020;61. Available from: https:\/\/www.nacblood.ca\/resources\/shortages-plan\/ The National Plan for Management of Shortages of Immunoglobulin Products (Ig) Interim Guidance_July 27 2020.Published.pdf"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925024903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:38:08Z","timestamp":1774701488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925024903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2531137925024903"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.106225","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.106225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106225"}}